HOME / Who is Piam / Our history

Our history since 1915

Projecting the present into the future

PIAM, the first company on the Italian market to work in the field of hereditary metabolic diseases, has introduced innovative and technologically advanced products, devoting itself to the development of increasingly effective, practical and highly palatable formulas with a view to improve treatment compliance.

PIAM works alongside Kyowa Hakko Bio, a world leader in biotechnology and chemical synthesis, with lines of amino acids, vitamins, nucleic acids and compounds for pharmaceutical and nutritional treatments.
PIAM is a long-standing partner of Vitaflo, a company that is specialized in human nutrition for the treatment of hereditary metabolic diseases and is part of the Nestlé Health Science group.

PIAM acts as a one-stop reference point on the market, with skills in the pharmaceutical and medical food areas, offering twofold expertise with a high degree of specialisation and diverse therapeutic treatments, customised for the management of rare and niche disorders.
PIAM’s commitment never stops and it focuses on investing in research and innovation in the orphan drugs sector, a strategic market that still requires a great deal of hard work because many rare diseases are lacking in accessible and adequate treatments.
PIAM continues to work alongside the scientific community and patients, constantly seeking out the best therapeutic solutions to protect the health of all patients.

1915

PIAM (Prodotti Igienici Alimentari Medicinali)
is founded in Genoa

1950-1960

Nicozid and Etapiam are launched on the market. PIAM establishes itself as market leader in the treatment of tuberculosis

1980

PIAM is the first pharmaceutical company to import medical food in Italy for treating hereditary metabolic diseases

2014

Change of ownership. New shareholders and majority stake, new management and a new strategic drive

2018

PIAM Iberia is founded to manage the business in Spain and Portugal

2022

In July 2022, with the acquisition of Bruschettini S.r.l., a leading pharmaceutical hub is created in the Ligurian capital

100 years by your side

Founded in 1915 in Genoa by Edoardo Maragliano, discoverer of the first tuberculosis vaccine, PIAM Farmaceutici is a dynamic Genoese company with a strong international vocation that successfully combines a century-old history with the innovative impetus of a startup.

This virtuous synthesis between tradition and innovation allows the company to stand out for its ability to face with agility the challenges of a complex and constantly changing sector.

Thanks to a forward-looking approach, PIAM has established itself as a major player in the global landscape in therapeutic areas such as Cardiovascular, Central Nervous System, Ophthalmic and Rare Diseases. An outcome of the integrated approach that combines innovation and quality with a vision strongly oriented to creating value for patients.

Our Figures

74

2023 turnover in million €
10% CAGR 2014-2019

35

CMO
(Contract Manufactor Organization)

100%

Presence
in Italian Hospital
Metabolic Centres

70

Partnerships with
Parkinson’s disease
treatment Centres

15

Projects underway
with Scientific
and Patient Associations

Read also

ETICA E TRASPARENZA

I NOSTRI VALORI

VISION E MISSION

SVILUPPO E INNOVAZIONE INCREMENTALE

IL TEAM